GlycoMimetics Number Of Shares Shorted vs. Price To Book

GLYC Stock  USD 0.32  0.01  3.03%   
Based on GlycoMimetics' profitability indicators, GlycoMimetics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess GlycoMimetics' ability to earn profits and add value for shareholders. At present, GlycoMimetics' Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's EV To Sales is expected to grow to about 11.4 K, whereas Operating Cash Flow Sales Ratio is projected to grow to (3.3 K). At present, GlycoMimetics' Non Operating Income Net Other is projected to increase significantly based on the last few years of reporting. The current year's Income Quality is expected to grow to 0.99, whereas Operating Income is forecasted to decline to (41.2 M).
For GlycoMimetics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GlycoMimetics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GlycoMimetics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GlycoMimetics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GlycoMimetics over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlycoMimetics. If investors know GlycoMimetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlycoMimetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.59)
Return On Equity
(1.04)
The market value of GlycoMimetics is measured differently than its book value, which is the value of GlycoMimetics that is recorded on the company's balance sheet. Investors also form their own opinion of GlycoMimetics' value that differs from its market value or its book value, called intrinsic value, which is GlycoMimetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlycoMimetics' market value can be influenced by many factors that don't directly affect GlycoMimetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlycoMimetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if GlycoMimetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlycoMimetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

GlycoMimetics Price To Book vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining GlycoMimetics's current stock value. Our valuation model uses many indicators to compare GlycoMimetics value to that of its competitors to determine the firm's financial worth.
GlycoMimetics is rated # 2 in number of shares shorted category among its peers. It is rated below average in price to book category among its peers . The ratio of Number Of Shares Shorted to Price To Book for GlycoMimetics is about  10,319,533 . As of November 23, 2024, Price To Book Ratio is expected to decline to 1.98. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GlycoMimetics' earnings, one of the primary drivers of an investment's value.

GlycoMimetics Price To Book vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

GlycoMimetics

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
5.64 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

GlycoMimetics

P/B

 = 

MV Per Share

BV Per Share

 = 
0.55 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

GlycoMimetics Price To Book Comparison

GlycoMimetics is currently under evaluation in price to book category among its peers.

GlycoMimetics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in GlycoMimetics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GlycoMimetics will eventually generate negative long term returns. The profitability progress is the general direction of GlycoMimetics' change in net profit over the period of time. It can combine multiple indicators of GlycoMimetics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-39.3 M-41.2 M
Income Before Tax-36.9 M-38.7 M
Total Other Income Expense Net2.4 M2.5 M
Net Loss-36.9 M-38.7 M
Income Tax Expense(637.00)(605.15)
Net Loss-42 M-44.1 M
Net Loss-38.1 M-40 M
Non Operating Income Net Other748.9 K786.3 K
Interest Income2.2 M1.3 M
Net Interest Income2.2 M1.4 M
Change To Netincome5.4 M4.9 M
Net Loss(0.58)(0.61)
Income Quality 0.95  0.99 
Net Income Per E B T 1.80  0.98 

GlycoMimetics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on GlycoMimetics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GlycoMimetics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GlycoMimetics' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in GlycoMimetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Use Investing Themes to Complement your GlycoMimetics position

In addition to having GlycoMimetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Education Thematic Idea Now

Education
Education Theme
Companies involved in apprenticeship, education, tutoring, schooling, online universities, and other learning services. The Education theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Education Theme or any other thematic opportunities.
View All  Next Launch
When determining whether GlycoMimetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GlycoMimetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Glycomimetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Glycomimetics Stock:
Check out Risk vs Return Analysis.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
To fully project GlycoMimetics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of GlycoMimetics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include GlycoMimetics' income statement, its balance sheet, and the statement of cash flows.
Potential GlycoMimetics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although GlycoMimetics investors may work on each financial statement separately, they are all related. The changes in GlycoMimetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GlycoMimetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.